Pharmaceutical intermediates

Jingkangen Biomedical provides different types of Pharmaceutical intermediates ranging from milligrams to kilograms scale (1000kg) with high quality and competitive prices.

View More +

Home - Products-JKN Signaling Pathways-ACT-1004-1239

ACT-1004-1239

CAS:

2178049-58-4

Cat No:

JKN00256

Purity:

98%

Inquire Now + Next Product +

Note: All products of the company are for scientific research only, and do not provide products and services for any individual

Product Description

CAS	2178049-58-4	Cat No	JKN00256
Name	ACT-1004-1239
Synonyms	ACT1004-1239
Smiles	O=C([C@@H]1[C@@H](NC(C2=NOC(C3=C(F)C=C(F)C=C3)=C2)=O)CCN(CC4CC4)C1)NC5(CC5)C6=NC=CC=N6
Chemical Name	N-((3S,4S)-1-(cyclopropylmethyl)-3-((1-(pyrimidin-2-yl)cyclopropyl)carbamoyl)piperidin-4-yl)-5-(2,4-difluorophenyl)isoxazole-3-carboxamide
Formula	C27H28F2N6O3	MWt	522.557
Purity	98%	Storage	Store at 4--8℃
Description	ACT-1004-1239 is a potent, insurmountable antagonist. Oral administration of ACT-1004-1239 in mice up to 100 mg/kg led to a dose-dependent increase of plasma CXCL12 concentration.

Product Documents

Products Category

Wuhan Jingkang en Biomedical Technology Co., Ltd.

Tel: +86 137 2013 4139

E-mail: orders@jknbiochem.com

Add.:Room 2120, Office Building 2, No.1 Baisha Fifth Road, Hongshan District, Wuhan City, Hubei Province, China

Get In Touch